XML 43 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2013
Fair Value Measurements  
Schedule of available-for-sale securities and derivative financial instruments measured at fair value

The fair value of the Company’s available-for-sale securities and derivative financial instruments were determined using the following inputs (dollars in thousands):

 

 

 

 

 

 

 

Fair Value Measurements

 

 

 

 

 

 

 

Using Fair Value Hierarchy

 

 

 

 

 

Carrying and

 

on a Recurring Basis

 

 

 

As of

 

Fair Value

 

Level 1

 

Level 2

 

Financial assets:

 

 

 

 

 

 

 

 

 

Available-for-sale securities:

 

September 30, 2013

 

$

286

 

$

286

 

$

 

Equity securities

 

December 31, 2012

 

278

 

278

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

September 30, 2013

 

166

 

 

166

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities:

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

September 30, 2013

 

1,416

 

 

1,416

 

 

 

December 31, 2012

 

1,470

 

 

1,470

 

Schedule of effect of derivative financial instruments on statement of income

The following table presents the effect of the Company’s derivative financial instruments on the statement of income for the periods presented (dollars in thousands):

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September  30,

 

 

 

2013

 

2012

 

2013

 

2012

 

Consolidated

 

 

 

 

 

 

 

 

 

Amount of (loss) recognized on derivatives in Other comprehensive (loss)

 

$

(972

)

$

(251

)

$

(372

)

$

(901

)

Amount of (loss) reclassification from Accumulated other comprehensive (loss) into Interest expense

 

(284

)

(133

)

(592

)

(371

)

 

 

 

 

 

 

 

 

 

 

Joint Ventures (Company’s share)

 

 

 

 

 

 

 

 

 

Amount of (loss) gain recognized on derivative in Other comprehensive (loss)

 

$

(15

)

$

(25

)

$

18

 

$

(78

)

Amount of (loss) reclassification from Accumulated other comprehensive (loss) into Equity in earnings of unconsolidated joint ventures

 

(14

)

(14

)

(42

)

(42

)